Canada markets closed

Cidara Therapeutics, Inc. (CDTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
12.00-0.71 (-5.59%)
At close: 04:00PM EDT
12.01 +0.01 (+0.08%)
After hours: 04:55PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-22,931
-22,931
-33,584
-42,467
-72,111
Depreciation & amortization
118
118
143
-1,230
1,050
Stock based compensation
3,061
3,061
3,532
4,014
4,090
Change in working capital
-3,920
-3,920
454
14,436
12,539
Accounts receivable
-10,413
-10,413
-477
5,819
-11,165
Inventory
-6,097
-6,097
0
-
-
Accounts Payable
8,886
8,886
-2,371
-
-
Other working capital
-22,937
-22,937
-28,591
-25,273
-54,597
Other non-cash items
1,240
1,240
982
15
21
Net cash provided by operating activites
-22,432
-22,432
-28,473
-25,232
-54,411
Cash flows from investing activities
Investments in property, plant and equipment
-505
-505
-118
-41
-186
Net cash used for investing activites
-505
-505
-118
-41
-186
Cash flows from financing activities
Debt repayment
0
0
-2,593
-4,444
-2,963
Common stock issued
25,963
25,963
2,362
49,035
40,227
Other financing activites
-
-
-720
-
-
Net cash used privided by (used for) financing activities
25,984
25,984
-951
44,597
37,278
Net change in cash
3,047
3,047
-29,542
19,324
-17,319
Cash at beginning of period
32,731
32,731
62,273
42,949
60,268
Cash at end of period
35,778
35,778
32,731
62,273
42,949
Free Cash Flow
Operating Cash Flow
-22,432
-22,432
-28,473
-25,232
-54,411
Capital Expenditure
-505
-505
-118
-41
-186
Free Cash Flow
-22,937
-22,937
-28,591
-25,273
-54,597